Brandywine Global Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,234
| Closed | -$3.47M | – | 580 |
|
|
2025
Q1 | $3.47M | Sell |
14,234
-290
| -2% | -$70.6K | 0.03% | 411 |
|
|
2024
Q4 | $4.77M | Sell |
14,524
-785
| -5% | -$258K | 0.03% | 370 |
|
|
2024
Q3 | $5.22M | Buy |
+15,309
| New | +$5.22M | 0.03% | 401 |
|
|
2023
Q4 | – | Sell |
-13,046
| Closed | -$4.68M | – | 694 |
|
|
2023
Q3 | $4.68M | Sell |
13,046
-1,003
| -7% | -$360K | 0.04% | 381 |
|
|
2023
Q2 | $5.33M | Sell |
14,049
-1,703
| -11% | -$646K | 0.04% | 366 |
|
|
2023
Q1 | $7.55M | Buy |
+15,752
| New | +$7.55M | 0.06% | 296 |
|
|
2022
Q2 | – | Sell |
-24,299
| Closed | -$13.7M | – | 726 |
|
|
2022
Q1 | $13.7M | Sell |
24,299
-610
| -2% | -$344K | 0.1% | 189 |
|
|
2021
Q4 | $18.8M | Sell |
24,909
-463
| -2% | -$350K | 0.13% | 160 |
|
|
2021
Q3 | $18.9M | Sell |
25,372
-1,204
| -5% | -$898K | 0.14% | 157 |
|
|
2021
Q2 | $17.1M | Sell |
26,576
-915
| -3% | -$590K | 0.13% | 174 |
|
|
2021
Q1 | $15.7M | Buy |
27,491
+7,688
| +39% | +$4.39M | 0.12% | 203 |
|
|
2020
Q4 | $11.5M | Sell |
19,803
-106
| -0.5% | -$61.8K | 0.1% | 223 |
|
|
2020
Q3 | $10.3M | Sell |
19,909
-795
| -4% | -$410K | 0.1% | 193 |
|
|
2020
Q2 | $9.35M | Buy |
20,704
+201
| +1% | +$90.8K | 0.1% | 198 |
|
|
2020
Q1 | $7.19M | Sell |
20,503
-242
| -1% | -$84.8K | 0.09% | 200 |
|
|
2019
Q4 | $7.72M | Sell |
20,745
-901
| -4% | -$335K | 0.05% | 299 |
|
|
2019
Q3 | $7.2M | Buy |
21,646
+471
| +2% | +$157K | 0.05% | 306 |
|
|
2019
Q2 | $6.62M | Buy |
21,175
+21,151
| +88,129% | +$6.61M | 0.05% | 347 |
|
|
2019
Q1 | $8K | Hold |
24
| – | – | ﹤0.01% | 796 |
|
|
2018
Q4 | $6K | Buy |
24
+10
| +71% | +$2.5K | ﹤0.01% | 785 |
|
|
2018
Q3 | $5K | Buy |
+14
| New | +$5K | ﹤0.01% | 814 |
|